The Business of Biotech was back in San Francisco for JPM in January, and offers here a few observations, highlights, and ...
Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today ...
Strategic Priorities and the Future of Life Sciences' Featuring Serina Therapeutics’ CEO - Wednesday, February ...
While much of the biopharma industry has spent the past 12 months treading lightly around the Trump administration and the tumult it has wrought on U.S. medical research and regulation, Pfizer’s CEO ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Industry leaders came away from ...
Jan 14 (Reuters) – Investors are eyeing a rebound in the U.S. biotech sector in 2026, as more companies are expected to go public amid a renewed deal-making appetite and a lower interest rate scenario ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results